Developer docs
API playgroundTry for free, no card

Search company profiles

RWEality

Full company profile

uuid002ah64

Namestring
RWEality
Legal namestring
RWEality
Websiteurl
rweality.com
Company typeenum
Private
Founded yearint
2023
Descriptiontext

RWEality is a Paris- and Bondoufle-based research and consulting firm founded in 2023 that specializes in Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) for the French healthcare market. The firm was co-founded by health economist Sandrine Bourguignon and biotech executive Jean-François Boyer, and operates as a SAS (Société par Actions Simplifiées) with €10,000 of share capital. Services are organized around three pillars — Strategy, Insights, and Operations — and cover RWE strategy development, HEOR modeling, market-access and pricing strategy, organizational and budget impact modeling (including the proprietary OBIM methodology), patient-pathway analysis, primary data generation (with partners Horiana and SKEZI), scientific communication, and training. Customers include pharmaceutical and biotechnology companies, medical-device manufacturers, French government and regional health agencies, patient associations, and health insurers; the firm's project portfolio is anchored in navigating French HTA processes (HAS, CEESP, CNEDIMTS, Article 51).

Revenue is generated exclusively through customized professional-service fees on a project basis, with no packaged products or standard pricing tiers publicly disclosed. The GTM motion is sales-led and direct: the firm markets through LinkedIn, YouTube webinars, and active speaker participation at ISPOR, ACIP, and SNITEM events, and delivers engagements through its in-house expert consultants rather than through intermediaries. The firm maintains a strategic partnership with Enosium Life Science (visible in co-branded logo/marketing), holds the registered RWEality trademark under Sandrine Bourguignon, and has developed a peer-reviewed publication track across journals such as Journal of Medical Economics, Therapie, and Value in Health. The operating model is bottlenecked by a small bench (approximately 10 team members including apprentices and interns), making senior-consultant utilization and repeat pharma/biotech engagement the primary scaling constraints.

Short descriptiontext

RWEality is a French consulting firm founded in 2023 that provides Real-World Evidence strategy, HEOR modeling, market access, and organizational impact assessments to pharmaceutical, biotechnology, medical device, government, and payer clients navigating the French HTA system.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersParis, France
HQ citystring
Paris
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare consulting services, real-world evidence research, health economics modeling, market access strategy, budget impact analysis
Industry4 codes
PRIMARYHLAGAAAK
Real-World Evidence (RWE), HEOR & Epidemiology CROs
SECONDARYBPAHALAN
Healthcare Outcomes & Real-World Evidence (RWE) Analytics
SECONDARYHLAIALAI
Real-World Evidence (RWE) & HEOR for Development
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
SECONDARYHLAGAOAN
Market Access, Pricing & Reimbursement (Evidence Generation) FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
NAICS code3 codes
  • Management Consulting Services54161
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Other Scientific and Technical Consulting Services54169
SIC code3 codes
  • Services-Engineering, Accounting, Research, Management8700
  • Services-Commercial Physical & Biological Research8731
  • Services-Management Consulting Services8742
Product category
Healthcare Economics Consulting
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Healthcare Consulting Services
TypeProfessional Services
Description

RWEality provides specialized consulting services including RWE strategy development, health economics and outcomes research (HEOR), market access and pricing strategy, organizational impact assessments, and economic modeling. Revenue is generated through professional service fees for studies, assessments, and strategic consulting engagements.

rweality.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details1 tier
1Consulting services with customized pricing based on project scope
ModelOtherBilling cadenceMulti-year contract
Notes

No standard pricing tiers publicly available. Services are tailored to client needs and quoted on a per-project basis.

rweality.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

RWEality is a research and consulting firm that evaluates public policies, healthcare technologies, and clinical practices for pharmaceutical, biotechnology, medical device, and institutional clients. The firm specializes in Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR), delivering economic modeling, market access and pricing strategy, organizational and budget impact assessments (OBIM), patient pathway analysis, data generation planning, and scientific communication support. Services are delivered by expert consultants and structured around four pillars: Strategy, Insights, Data Generation, and Communication.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Multiple peer-reviewed publications in health economics journals including Journal of Medical Economics, Journal of Liver Transplantation, Therapie, ESC Heart Fail, and Value in Health
+1 more record
Product overview1 text field

RWEality is a healthcare consulting firm offering end-to-end services organized around three pillars: Strategy, Insights, and Operations. The company provides RWE Strategy services (including RWE plan, investment, gap analysis, and market access), Insight services (HEOR modeling, organizational and budget impact assessment), Data Generation Plan services (data collection, management, statistical analysis, secondary data sources), and Communication services. Their core offerings are consulting and advisory services rather than a software product platform. They work with pharmaceutical, biotech, medical device companies, and healthcare institutions to demonstrate the value of healthcare technologies through robust methodologies, data analysis, and strategic market access support.

Product and service7 records
1RWE Strategy Services
CategoryConsulting service pillar
2Insight Services (HEOR)
CategoryConsulting service pillar
3Data Generation Plan
CategoryConsulting service pillar
4Communication Services
CategoryConsulting service pillar
5Organizational and Budget Impact Model (OBIM)
CategoryProprietary HEOR methodology
6Local Market Access Services
CategoryMarket access service
7Value Communication & Training
CategoryTraining and enablement service
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic partnership for life sciences consulting and research collaboration in the healthcare sector.

Strategic tierCoreTypeTechnology or Integration
Description

Data generation partner for collection, data management, and statistical analysis services. Collaboration specifically mentioned in data generation services section.

Strategic tierCoreTypeTechnology or Integration
Description

Data generation partner for data collection and statistical analysis. Collaboration mentioned for data generation services including PRO data and digital health solutions.

4Perrine Bocquin
Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

Website designer and developer providing web development services for the company website.

rweality.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global consulting firm with a Life Sciences practice providing HEOR, pricing, market access, and value strategy services. Competes for pharma/biotech HEOR and pricing engagements with similar deep economic expertise.

TypeBroad incumbent
Description

Global CRO with significant HEOR, RWE, and market access consulting capabilities post-PRA Health Sciences acquisition. Competes with RWEality on large pharma RWE and value demonstration engagements.

TypeBroad incumbent
Description

Global life sciences and healthcare data giant with extensive HEOR, RWE, and market access consulting practices. Several RWEality team alumni (Nathalie Grémaud, Enguérand Dautel) previously worked at IQVIA, and IQVIA serves as both a competitor and a source of trained talent.

TypeDirect peer
Description

Strategy consulting firm focused on biopharmaceutical market access, pricing, and HEOR. Competes with RWEality on pharma/biotech pricing strategy and value demonstration engagements.

TypeBroad incumbent
Description

Large pharmaceutical distribution and consulting services provider with market access and HEOR capabilities serving pharma manufacturers. Competes in the broader market access and value demonstration space.

TypeRegional player
Description

French public affairs and health economics consulting firm where RWEality's Public Health Director Nathalie Grémaud previously worked. Directly competes for French healthcare market access and policy engagements.

TypeDirect peer
Description

Global healthcare and life sciences consulting firm offering RWE, HEOR, market access, and patient-centric services. RWEality's Analyst José Fernandes Soares previously worked at Alira Health, and the firms compete for similar pharma/biotech/medical device RWE/HEOR engagements.

TypeDirect peer
Description

Major global RWE/HEOR consulting firm within PPD/Thermo Fisher Scientific, offering health economics, market access, and real-world evidence services to pharma and biotech. Competes with RWEality on large enterprise RWE and HEOR engagements.

9Niveco
TypeRegional player
Description

French health economics and market access consulting boutique serving pharma and medical device clients with HEOR, pricing, and reimbursement services. Closest French boutique peer competing for the same client base.

TypeDirect peer
Description

European life sciences consulting firm with RWE, HEOR, and market access practices. RWEality has a Core strategic partnership with Enosium, and the firms operate in adjacent/similar European healthcare consulting niches.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

RWEality

Healthcare Economics Consultingrweality.com

RWEality is a French consulting firm founded in 2023 that provides Real-World Evidence strategy, HEOR modeling, market access, and organizational impact assessments to pharmaceutical, biotechnology, medical device, government, and payer clients navigating the French HTA system.

What RWEality does

RWEality is a Paris- and Bondoufle-based research and consulting firm founded in 2023 that specializes in Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) for the French healthcare market. The firm was co-founded by health economist Sandrine Bourguignon and biotech executive Jean-François Boyer, and operates as a SAS (Société par Actions Simplifiées) with €10,000 of share capital. Services are organized around three pillars — Strategy, Insights, and Operations — and cover RWE strategy development, HEOR modeling, market-access and pricing strategy, organizational and budget impact modeling (including the proprietary OBIM methodology), patient-pathway analysis, primary data generation (with partners Horiana and SKEZI), scientific communication, and training. Customers include pharmaceutical and biotechnology companies, medical-device manufacturers, French government and regional health agencies, patient associations, and health insurers; the firm's project portfolio is anchored in navigating French HTA processes (HAS, CEESP, CNEDIMTS, Article 51).

Revenue is generated exclusively through customized professional-service fees on a project basis, with no packaged products or standard pricing tiers publicly disclosed. The GTM motion is sales-led and direct: the firm markets through LinkedIn, YouTube webinars, and active speaker participation at ISPOR, ACIP, and SNITEM events, and delivers engagements through its in-house expert consultants rather than through intermediaries. The firm maintains a strategic partnership with Enosium Life Science (visible in co-branded logo/marketing), holds the registered RWEality trademark under Sandrine Bourguignon, and has developed a peer-reviewed publication track across journals such as Journal of Medical Economics, Therapie, and Value in Health. The operating model is bottlenecked by a small bench (approximately 10 team members including apprentices and interns), making senior-consultant utilization and repeat pharma/biotech engagement the primary scaling constraints.

RWEality firmographics

Firmographics
Name
RWEality
Legal name
RWEality
Website
https://rweality.com
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
1–10 employees
Short description
RWEality is a French consulting firm founded in 2023 that provides Real-World Evidence strategy, HEOR modeling, market access, and organizational impact assessments to pharmaceutical, biotechnology, medical device, government, and payer clients navigating the French HTA system.
Ownership category
akta.pro rank

RWEality industry classification

Industry
Product category
Healthcare Economics Consulting
NAICS
Management Consulting Services (54161), Research and Development in the Physical, Engineering, and Life Sciences (54171), Other Scientific and Technical Consulting Services (54169)
SIC
Services-Engineering, Accounting, Research, Management (8700), Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYHLAGAAAK
Real-World Evidence (RWE), HEOR & Epidemiology CROs
SECONDARYBPAHALAN
Healthcare Outcomes & Real-World Evidence (RWE) Analytics
SECONDARYHLAIALAI
Real-World Evidence (RWE) & HEOR for Development
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development
SECONDARYHLAGAOAN
Market Access, Pricing & Reimbursement (Evidence Generation) FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

Keywords

  • Healthcare consulting services
  • Real-world evidence research
  • Health economics modeling
  • Market access strategy
  • Budget impact analysis

Where RWEality is headquartered

Location

Headquarters

HQ city
Paris
HQ country
France
HQ region
Europe

Offices2 records

Markets served

RWEality business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Healthcare Consulting Services: RWEality provides specialized consulting services including RWE strategy development, health economics and outcomes research (HEOR), market access and pricing strategy, organizational impact assessments, and economic modeling. Revenue is generated through professional service fees for studies, assessments, and strategic consulting engagements.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractConsulting services with customized pricing based on project scope

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

RWEality product offering

Product offering

Core offering

RWEality is a research and consulting firm that evaluates public policies, healthcare technologies, and clinical practices for pharmaceutical, biotechnology, medical device, and institutional clients. The firm specializes in Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR), delivering economic modeling, market access and pricing strategy, organizational and budget impact assessments (OBIM), patient pathway analysis, data generation planning, and scientific communication support. Services are delivered by expert consultants and structured around four pillars: Strategy, Insights, Data Generation, and Communication.

Product overview

RWEality is a healthcare consulting firm offering end-to-end services organized around three pillars: Strategy, Insights, and Operations. The company provides RWE Strategy services (including RWE plan, investment, gap analysis, and market access), Insight services (HEOR modeling, organizational and budget impact assessment), Data Generation Plan services (data collection, management, statistical analysis, secondary data sources), and Communication services. Their core offerings are consulting and advisory services rather than a software product platform. They work with pharmaceutical, biotech, medical device companies, and healthcare institutions to demonstrate the value of healthcare technologies through robust methodologies, data analysis, and strategic market access support.

Differentiator

Problem solved

Functional benefit

Products and services

  • RWE Strategy Services
  • Insight Services (HEOR)
  • Data Generation Plan
  • Communication Services
  • Organizational and Budget Impact Model (OBIM)
  • Local Market Access Services
  • Value Communication & Training

Quantifiable outcome

  • Multiple peer-reviewed publications in health economics journals including Journal of Medical Economics, Journal of Liver Transplantation, Therapie, ESC Heart Fail, and Value in Health
  • +1 more outcomes

Companies that use RWEality

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles4 records

RWEality technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

RWEality partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • Enosium Life SciencecoreStrategic or Co-development PartnerStrategic partnership for life sciences consulting and research collaboration in the healthcare sector.
  • HorianacoreTechnology or IntegrationData generation partner for collection, data management, and statistical analysis services. Collaboration specifically mentioned in data generation services section.
  • SKEZIcoreTechnology or IntegrationData generation partner for data collection and statistical analysis. Collaboration mentioned for data generation services including PRO data and digital health solutions.
  • Perrine BocquinminorImplementation/ SI/ Consulting PartnerWebsite designer and developer providing web development services for the company website.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

RWEality competitors and assessment

Company assessment

Direct peers

  • Charles River Associates (CRA): Global consulting firm with a Life Sciences practice providing HEOR, pricing, market access, and value strategy services. Competes for pharma/biotech HEOR and pricing engagements with similar deep economic expertise.
  • Putnam Associates: Strategy consulting firm focused on biopharmaceutical market access, pricing, and HEOR. Competes with RWEality on pharma/biotech pricing strategy and value demonstration engagements.
  • Alira Health: Global healthcare and life sciences consulting firm offering RWE, HEOR, market access, and patient-centric services. RWEality's Analyst José Fernandes Soares previously worked at Alira Health, and the firms compete for similar pharma/biotech/medical device RWE/HEOR engagements.
  • Evidera (PPD / Thermo Fisher): Major global RWE/HEOR consulting firm within PPD/Thermo Fisher Scientific, offering health economics, market access, and real-world evidence services to pharma and biotech. Competes with RWEality on large enterprise RWE and HEOR engagements.
  • Enosium Life Science: European life sciences consulting firm with RWE, HEOR, and market access practices. RWEality has a Core strategic partnership with Enosium, and the firms operate in adjacent/similar European healthcare consulting niches.

Broad incumbents

  • ICON plc: Global CRO with significant HEOR, RWE, and market access consulting capabilities post-PRA Health Sciences acquisition. Competes with RWEality on large pharma RWE and value demonstration engagements.
  • IQVIA: Global life sciences and healthcare data giant with extensive HEOR, RWE, and market access consulting practices. Several RWEality team alumni (Nathalie Grémaud, Enguérand Dautel) previously worked at IQVIA, and IQVIA serves as both a competitor and a source of trained talent.
  • Cencora (formerly AmerisourceBergen) Consulting Services: Large pharmaceutical distribution and consulting services provider with market access and HEOR capabilities serving pharma manufacturers. Competes in the broader market access and value demonstration space.

Regional players

  • Stratégique Santé: French public affairs and health economics consulting firm where RWEality's Public Health Director Nathalie Grémaud previously worked. Directly competes for French healthcare market access and policy engagements.
  • Niveco: French health economics and market access consulting boutique serving pharma and medical device clients with HEOR, pricing, and reimbursement services. Closest French boutique peer competing for the same client base.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

RWEality social profiles

Digital presence

RWEality financial estimates

Financial estimate

Revenue estimate

Valuation estimate

RWEality leadership team

Management profile

Number of profiles

Profiles10 records

RWEality funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

RWEality M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RWEality

What does RWEality do?

RWEality is a research and consulting firm that evaluates public policies, healthcare technologies, and clinical practices for pharmaceutical, biotechnology, medical device, and institutional clients. The firm specializes in Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR), delivering economic modeling, market access and pricing strategy, organizational and budget impact assessments (OBIM), patient pathway analysis, data generation planning, and scientific communication support. Services are delivered by expert consultants and structured around four pillars: Strategy, Insights, Data Generation, and Communication.

Is RWEality a public or private company?

RWEality is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was RWEality founded?

RWEality was founded in 2023. It employs 1 to 10 people.

Where is RWEality based?

RWEality is headquartered in Paris, France, in the Europe region.

How does RWEality make money?

One revenue line is on record: healthcare Consulting Services.

Who are RWEality's main competitors?

Direct peers on record are Charles River Associates (CRA), Putnam Associates, Alira Health, Evidera (PPD / Thermo Fisher) and Enosium Life Science. Broad incumbents are ICON plc, IQVIA and Cencora (formerly AmerisourceBergen) Consulting Services. Regional players are Stratégique Santé and Niveco.

Does RWEality have an API?

No public API is recorded for RWEality.

What industry is RWEality in?

RWEality's product category is Healthcare Economics Consulting. Its primary akta.pro industry code is HLAGAAAK, Real-World Evidence (RWE), HEOR & Epidemiology CROs, with a secondary code of BPAHALAN, Healthcare Outcomes & Real-World Evidence (RWE) Analytics. Its NAICS code is 54161 and its SIC code is 8700.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals